G-protein therapeutics (Cadus/BMS)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameG-protein therapeutics (Cadus/BMS)
Drug Alias NameG-protein therapeutics (Bristol-Myers Squibb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsInflammationObesityDiabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCadus Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCadus CorpBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammationObesityDiabetes Mellitus +[5] 

Other Information

ATC CodeN/A
Related LinksN/A